Impact of setanaxib on quality of life outcomes in primary biliary cholangitis in a phase 2 randomized controlled trial.

David E J Jones Marco Carbone Invernizzi Pietro Nicola Little Frederik Nevens Mark G Swain Philippe Wiesel Cynthia Levy

Published in: Hepatology communications (2023)

These results support further investigation of setanaxib as a treatment for patients with PBC, particularly for those with clinically significant fatigue.

Keyphrases

randomized controlled trial
systematic review
sleep quality
type diabetes
combination therapy
metabolic syndrome
physical activity
ulcerative colitis
skeletal muscle
replacement therapy